 | • レポートコード：B-GIR09D3834 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、CAR T細胞免疫療法の世界市場について調べ、まとめました。種類別セグメントは、単独療法、併用療法等、用途別セグメントは、血液悪性腫瘍、固形悪性腫瘍等に区分しました。CAR T細胞免疫療法の世界市場概観、企業動向、企業別CAR T細胞免疫療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・CAR T細胞免疫療法の市場概観 ・CAR T細胞免疫療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・CAR T細胞免疫療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・CAR T細胞免疫療法の世界市場規模 ・CAR T細胞免疫療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・CAR T細胞免疫療法のアメリカ市場規模推移 ・CAR T細胞免疫療法のカナダ市場規模推移 ・CAR T細胞免疫療法のメキシコ市場規模推移 ・CAR T細胞免疫療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・CAR T細胞免疫療法のドイツ市場規模推移 ・CAR T細胞免疫療法のイギリス市場規模推移 ・CAR T細胞免疫療法のロシア市場規模推移 ・CAR T細胞免疫療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・CAR T細胞免疫療法の日本市場規模推移 ・CAR T細胞免疫療法の中国市場規模推移 ・CAR T細胞免疫療法の韓国市場規模推移 ・CAR T細胞免疫療法のインド市場規模推移 ・CAR T細胞免疫療法の東南アジア市場規模推移 ・CAR T細胞免疫療法の南米市場分析（ブラジル、アルゼンチン等） ・CAR T細胞免疫療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・CAR T細胞免疫療法の種類別分析/販売量、売上、市場シェア（単独療法、併用療法） ・CAR T細胞免疫療法の用途別分析/市場規模（血液悪性腫瘍、固形悪性腫瘍） ・CAR T細胞免疫療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・CAR T細胞免疫療法の販売チャネル・代理店・貿易業者・ディーラー分析 |
CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.
Scope of the Report:
The global CAR T-Cell Immunotherapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of CAR T-Cell Immunotherapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the CAR T-Cell Immunotherapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the CAR T-Cell Immunotherapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monotherapy
Combination Therapy
Market Segment by Applications, can be divided into
Hematologic Malignancies
Solid Malignancies
Table of Contents
1 CAR T-Cell Immunotherapy Market Overview
1.1 Product Overview and Scope of CAR T-Cell Immunotherapy
1.2 Classification of CAR T-Cell Immunotherapy by Types
1.2.1 Global CAR T-Cell Immunotherapy Revenue Comparison by Types (2019-2024)
1.2.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Types in 2018
1.2.3 Monotherapy
1.2.4 Combination Therapy
1.3 Global CAR T-Cell Immunotherapy Market by Application
1.3.1 Global CAR T-Cell Immunotherapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hematologic Malignancies
1.3.3 Solid Malignancies
1.4 Global CAR T-Cell Immunotherapy Market by Regions
1.4.1 Global CAR T-Cell Immunotherapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CAR T-Cell Immunotherapy Status and Prospect (2014-2024)
1.5 Global Market Size of CAR T-Cell Immunotherapy (2014-2024)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 CAR T-Cell Immunotherapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Celgene
2.2.1 Business Overview
2.2.2 CAR T-Cell Immunotherapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Kite Pharma
2.3.1 Business Overview
2.3.2 CAR T-Cell Immunotherapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Oxford BioMedica
2.4.1 Business Overview
2.4.2 CAR T-Cell Immunotherapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novartis
2.5.1 Business Overview
2.5.2 CAR T-Cell Immunotherapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Gilead
2.6.1 Business Overview
2.6.2 CAR T-Cell Immunotherapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 CAR T-Cell Immunotherapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Cellectis
2.8.1 Business Overview
2.8.2 CAR T-Cell Immunotherapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bellicum
2.9.1 Business Overview
2.9.2 CAR T-Cell Immunotherapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 Mustang Bio
2.10.1 Business Overview
2.10.2 CAR T-Cell Immunotherapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 CARsgen Therapeutics
2.11.1 Business Overview
2.11.2 CAR T-Cell Immunotherapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.12 Xyphos
2.12.1 Business Overview
2.12.2 CAR T-Cell Immunotherapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.13 Minerva Biotechnologies
2.13.1 Business Overview
2.13.2 CAR T-Cell Immunotherapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.14 Adaptimmune
2.14.1 Business Overview
2.14.2 CAR T-Cell Immunotherapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.15 Ziopharm Oncology
2.15.1 Business Overview
2.15.2 CAR T-Cell Immunotherapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.16 Aurora Biopharma
2.16.1 Business Overview
2.16.2 CAR T-Cell Immunotherapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.17 Creative Biolabs
2.17.1 Business Overview
2.17.2 CAR T-Cell Immunotherapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global CAR T-Cell Immunotherapy Market Competition, by Players
3.1 Global CAR T-Cell Immunotherapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 CAR T-Cell Immunotherapy Players Market Share
3.2.2 Top 10 CAR T-Cell Immunotherapy Players Market Share
3.3 Market Competition Trend
4 Global CAR T-Cell Immunotherapy Market Size by Regions
4.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Regions
4.2 North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
4.3 Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
4.5 South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
5 North America CAR T-Cell Immunotherapy Revenue by Countries
5.1 North America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
5.2 USA CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
5.3 Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
5.4 Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
6 Europe CAR T-Cell Immunotherapy Revenue by Countries
6.1 Europe CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
6.2 Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
6.3 UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
6.4 France CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
6.5 Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
6.6 Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries
7.1 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
7.2 China CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
7.3 Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
7.4 Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
7.5 India CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
8 South America CAR T-Cell Immunotherapy Revenue by Countries
8.1 South America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
8.2 Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
8.3 Argentina CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
8.4 Colombia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue CAR T-Cell Immunotherapy by Countries
9.1 Middle East and Africa CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
9.3 UAE CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
9.4 Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
9.6 South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
10 Global CAR T-Cell Immunotherapy Market Segment by Type
10.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Type (2014-2019)
10.2 Global CAR T-Cell Immunotherapy Market Forecast by Type (2019-2024)
10.3 Monotherapy Revenue Growth Rate (2014-2024)
10.4 Combination Therapy Revenue Growth Rate (2014-2024)
11 Global CAR T-Cell Immunotherapy Market Segment by Application
11.1 Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2014-2019)
11.2 CAR T-Cell Immunotherapy Market Forecast by Application (2019-2024)
11.3 Hematologic Malignancies Revenue Growth (2014-2019)
11.4 Solid Malignancies Revenue Growth (2014-2019)
12 Global CAR T-Cell Immunotherapy Market Size Forecast (2019-2024)
12.1 Global CAR T-Cell Immunotherapy Market Size Forecast (2019-2024)
12.2 Global CAR T-Cell Immunotherapy Market Forecast by Regions (2019-2024)
12.3 North America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
12.4 Europe CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
12.6 South America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure CAR T-Cell Immunotherapy Picture
Table Product Specifications of CAR T-Cell Immunotherapy
Table Global CAR T-Cell Immunotherapy and Revenue (Million USD) Market Split by Product Type
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Types in 2018
Figure Monotherapy Picture
Figure Combination Therapy Picture
Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Application (2014-2024)
Figure CAR T-Cell Immunotherapy Revenue Market Share by Applications in 2018
Figure Hematologic Malignancies Picture
Figure Solid Malignancies Picture
Table Global Market CAR T-Cell Immunotherapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie CAR T-Cell Immunotherapy Type and Applications
Table AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene CAR T-Cell Immunotherapy Type and Applications
Table Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Kite Pharma Basic Information, Manufacturing Base and Competitors
Table Kite Pharma CAR T-Cell Immunotherapy Type and Applications
Table Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Oxford BioMedica Basic Information, Manufacturing Base and Competitors
Table Oxford BioMedica CAR T-Cell Immunotherapy Type and Applications
Table Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis CAR T-Cell Immunotherapy Type and Applications
Table Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead CAR T-Cell Immunotherapy Type and Applications
Table Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer CAR T-Cell Immunotherapy Type and Applications
Table Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cellectis Basic Information, Manufacturing Base and Competitors
Table Cellectis CAR T-Cell Immunotherapy Type and Applications
Table Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bellicum Basic Information, Manufacturing Base and Competitors
Table Bellicum CAR T-Cell Immunotherapy Type and Applications
Table Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Mustang Bio Basic Information, Manufacturing Base and Competitors
Table Mustang Bio CAR T-Cell Immunotherapy Type and Applications
Table Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table CARsgen Therapeutics Basic Information, Manufacturing Base and Competitors
Table CARsgen Therapeutics CAR T-Cell Immunotherapy Type and Applications
Table CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Xyphos Basic Information, Manufacturing Base and Competitors
Table Xyphos CAR T-Cell Immunotherapy Type and Applications
Table Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Minerva Biotechnologies Basic Information, Manufacturing Base and Competitors
Table Minerva Biotechnologies CAR T-Cell Immunotherapy Type and Applications
Table Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Adaptimmune Basic Information, Manufacturing Base and Competitors
Table Adaptimmune CAR T-Cell Immunotherapy Type and Applications
Table Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Ziopharm Oncology Basic Information, Manufacturing Base and Competitors
Table Ziopharm Oncology CAR T-Cell Immunotherapy Type and Applications
Table Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Aurora Biopharma Basic Information, Manufacturing Base and Competitors
Table Aurora Biopharma CAR T-Cell Immunotherapy Type and Applications
Table Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table Creative Biolabs CAR T-Cell Immunotherapy Type and Applications
Table Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Players (2014-2019)
Table Global CAR T-Cell Immunotherapy Revenue Share by Players (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Players in 2017
Figure Global CAR T-Cell Immunotherapy Revenue Share by Players in 2018
Figure Global Top 5 Players CAR T-Cell Immunotherapy Revenue Market Share in 2018
Figure Global Top 10 Players CAR T-Cell Immunotherapy Revenue Market Share in 2018
Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Regions (2014-2019)
Table Global CAR T-Cell Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Regions in 2018
Figure North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Table North America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
Table North America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018
Figure USA CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Table Europe CAR T-Cell Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018
Figure Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure France CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific CAR T-Cell Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018
Figure China CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure India CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Table South America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019)
Table South America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018
Figure Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Argentina CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Colombia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UAE CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Nigeria CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019)
Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Type (2014-2019)
Table Global CAR T-Cell Immunotherapy Revenue Share by Type (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Type (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Type in 2019
Table Global CAR T-Cell Immunotherapy Revenue Forecast by Type (2019-2024)
Figure Global CAR T-Cell Immunotherapy Market Share Forecast by Type (2019-2024)
Figure Global Monotherapy Revenue Growth Rate (2014-2019)
Figure Global Combination Therapy Revenue Growth Rate (2014-2019)
Table Global CAR T-Cell Immunotherapy Revenue by Application (2014-2019)
Table Global CAR T-Cell Immunotherapy Revenue Share by Application (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Application (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue Share by Application in 2019
Table Global CAR T-Cell Immunotherapy Revenue Forecast by Application (2019-2024)
Figure Global CAR T-Cell Immunotherapy Market Share Forecast by Application (2019-2024)
Figure Global Hematologic Malignancies Revenue Growth Rate (2014-2019)
Figure Global Solid Malignancies Revenue Growth Rate (2014-2019)
Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global CAR T-Cell Immunotherapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global CAR T-Cell Immunotherapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
Figure Europe CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
Figure South America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)
世界の皮下免疫療法市場予測（～2024年） Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism. Scope of the Report: The global Subcutaneous Immunotherapy market is valued at xx million USD in…- 世界の舌下免疫療法市場予測（～2024年） Sublingual immunotherapy is an alternative way to treat allergies without injections. An allergist gives a patient small doses of an allergen under the tongue to boost tolerance to the substance and reduce symptoms. Scope of the Report: The global Sublingual Immunotherapy market is valued at xx mill…
- 世界の筋骨格障害幹細胞療法市場予測（～2024年） Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy. Scope of the Report: The global Musculoskeletal Disorder Stem Cell Therapy market is valued at xx million USD in 2018 and is expected to reach…
- 世界のリファービッシュ携帯電話市場予測（～2024年） Refurbished cell phones are basically those mobile phones which are returned to the seller because of some manufacturing and functioning defect, then it is taken back by seller and than these electronics or items are repaired again under full quality check with best industrial standards and sold aga…
- 世界の生細胞カプセル化市場予測（～2024年） Scope of the Report: The global Live Cell Encapsulation market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…